Farallon Capital Management 13F holdings
The latest 13F-HR filed by Farallon Capital Management covers the period ending 2026-09-30, with 116 reported positions. The largest positions by reported value are below, as filed.
Portfolio shape
Farallon Capital Management's largest reported position at September 30, 2026 was STATE STR SPDR S&P 500 ETF T at 17.1% of the $23.2B it reported, followed by REVOLUTION MEDICINES INC (11.9%).
The 10 largest positions shown make up 60.6% of reported value across 116 positions, so the rest of the portfolio holds 39.4%.
| # | Issuer | Class | CUSIP | Value | Shares | Weight |
|---|---|---|---|---|---|---|
| 1 | STATE STR SPDR S&P 500 ETF T | TR UNIT | 78462F103 | $3,980,928,600 | 5,220,000 | 17.1% |
| 2 | REVOLUTION MEDICINES INC | COM | 76155X100 | $2,754,342,067 | 13,418,796 | 11.9% |
| 3 | WARNER BROS DISCOVERY INC | COM SER A | 934423104 | $1,528,074,047 | 49,372,344 | 6.6% |
| 4 | NATERA INC | COM | 632307104 | $1,074,460,515 | 2,599,648 | 4.6% |
| 5 | BRIDGEBIO PHARMA INC | COM | 10806X102 | $937,452,600 | 14,247,000 | 4.0% |
| 6 | PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | $907,036,576 | 6,437,906 | 3.9% |
| 7 | EXELIXIS INC | COM | 30161Q104 | $858,329,693 | 14,694,910 | 3.7% |
| 8 | ROIVANT SCIENCES LTD | SHS | G76279101 | $795,234,142 | 21,745,533 | 3.4% |
| 9 | ROKU INC | COM CL A | 77543R102 | $633,492,262 | 4,160,049 | 2.7% |
| 10 | AMAZON COM INC | COM | 023135106 | $590,102,806 | 2,368,464 | 2.5% |
What Farallon Capital Management bought, added, trimmed and exited
The free view above is the top of one quarter's filing. The paid report diffs the two most recent 13F filings, so you see new positions, adds, trims and exits with the size of each move, a cited write-up, and the full holdings plus changes table to download.
Generated from public SEC EDGAR filings. Filing data is shown as filed. This is information, not investment advice.